content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

AxoGen, Inc. (AXGN)

35.85
-0.15
(-0.42%)
Sep 11, 4:00PM EDT
content_middle

AxoGen (AXGN) is a medical technology company dedicated to peripheral nerve repair.

AXGN's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments.

Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed.

In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin.

AXGN provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally.

AxoGen, Inc. is headquartered in Alachua, Florida.

Previous Close: 
18.15
Open: 
18.00
Bid: 
17.60
Ask: 
21.70
1yr Target Price: 
18.67
Day's Range: 
17.90 - 18.40
52wk Range: 
18.10 - 56.85
Volume: 
208290
Average Daily Volume: 
199324
Market Capitalization: 
1,373.88M
Trailing Annual Dividend Yield: 
0.00
Shares Outstanding: 
38.32M
content_right

Pages